Citic Securities

China genomics giant BGI targets A-share IPO

BGI, one of the world’s largest genome sequencing firms, plans to list in China to help fund growth and acquisitions but it is unclear if the IPO will see light in 2016.
April 12, 2016

Citic Securities lays it on FICC

In an exclusive interview, Citic Securities’s John Sun explains how the firm is expanding in London to offer European investors more access to offshore renminbi products and Asian dollar debt.
December 03, 2015